Group One Trading, L.P. Celldex Therapeutics, Inc. Transaction History

Group One Trading, L.P.

  • $3.01 Billion
  • Q2 2024

A detailed history of Group One Trading, L.P. transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 8,757 shares of CLDX stock, worth $229,608. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,757
Previous 9,356 6.4%
Holding current value
$229,608
Previous $392,000 17.35%
% of portfolio
0.01%
Previous 0.01%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$32.76 - $42.56 $19,623 - $25,493
-599 Reduced 6.4%
8,757 $324,000
Q1 2024

May 10, 2024
SELL
$35.22 - $51.88 $428,979 - $631,898
-12,180 Reduced 56.56%
9,356 $392,000
Q4 2023

Feb 14, 2024
BUY
$22.61 - $40.65 $85,465 - $153,657
3,780 Added 21.29%
21,536 $854,000
Q3 2023

Nov 09, 2023
SELL
$25.45 - $37.46 $346,349 - $509,793
-13,609 Reduced 43.39%
17,756 $488,000
Q2 2023

Aug 09, 2023
BUY
$30.29 - $38.28 $340,489 - $430,305
11,241 Added 55.86%
31,365 $1.06 Million
Q1 2023

May 12, 2023
BUY
$34.78 - $47.43 $456,174 - $622,091
13,116 Added 187.16%
20,124 $724,000
Q4 2022

Feb 09, 2023
SELL
$27.78 - $45.38 $188,376 - $307,721
-6,781 Reduced 49.18%
7,008 $312,000
Q3 2022

Nov 09, 2022
SELL
$22.7 - $37.57 $329,853 - $545,929
-14,531 Reduced 51.31%
13,789 $388,000
Q2 2022

Aug 11, 2022
BUY
$20.5 - $37.33 $175,152 - $318,947
8,544 Added 43.2%
28,320 $764,000
Q1 2022

May 12, 2022
SELL
$27.64 - $39.32 $702,940 - $999,986
-25,432 Reduced 56.26%
19,776 $674,000
Q4 2021

Feb 11, 2022
BUY
$35.68 - $56.27 $640,705 - $1.01 Million
17,957 Added 65.89%
45,208 $1.75 Million
Q3 2021

Nov 12, 2021
BUY
$28.95 - $55.99 $28,023 - $54,198
968 Added 3.68%
27,251 $1.47 Million
Q2 2021

Aug 10, 2021
SELL
$20.71 - $35.37 $1.17 Million - $1.99 Million
-56,354 Reduced 68.19%
26,283 $879,000
Q1 2021

May 12, 2021
BUY
$16.19 - $29.91 $946,758 - $1.75 Million
58,478 Added 242.05%
82,637 $1.7 Million
Q4 2020

Feb 10, 2021
BUY
$14.99 - $22.75 $362,143 - $549,617
24,159 New
24,159 $423,000
Q2 2020

Aug 13, 2020
SELL
$1.61 - $13.41 $16,204 - $134,971
-10,065 Closed
0 $0
Q1 2020

May 13, 2020
SELL
$1.55 - $3.07 $1,247 - $2,471
-805 Reduced 7.41%
10,065 $17,000
Q4 2019

Feb 10, 2020
SELL
$2.11 - $2.8 $14,700 - $19,507
-6,967 Reduced 39.06%
10,870 $24,000
Q3 2019

Nov 12, 2019
BUY
$2.05 - $2.75 $22,344 - $29,975
10,900 Added 157.13%
17,837 $38,000
Q2 2019

Aug 09, 2019
SELL
$2.43 - $5.09 $9,746 - $20,415
-4,011 Reduced 36.64%
6,937 $19,000
Q1 2019

May 13, 2019
BUY
$3.45 - $10.35 $37,770 - $113,311
10,948 New
10,948 $54,000

Others Institutions Holding CLDX

# of Institutions
195
Shares Held
64.1M
Call Options Held
212K
Put Options Held
176K
View Full List

About Celldex Therapeutics, Inc.

CLDX Quotes by TradingView
  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.23B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email